https://doi.org/10.4081/monaldi.2022.2145
Thyroid dysfunction on the heart: clinical effects, prognostic impact and management strategies
Submitted: November 7, 2021
Accepted: March 8, 2022
Published: March 24, 2022
Accepted: March 8, 2022
Abstract Views: 1520
PDF: 544
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Thyroid hormones have a considerable influence on cardiac function and structure. There are direct and indirect effects of thyroid hormone on the cardiovascular system, which are prominent in both hypothyroidism and hyperthyroidism. In this review, we discuss how thyroid dysfunction impacts cardiovascular pathophysiology and the underlying molecular mechanisms.
Irace L, Pergola V, Di Salvo G, et al. Work capacity and oxygen uptake abnormalities in hyperthyroidism. Minerva Cardioangiol 2006;54:355-62.
Biondi B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol 2012;167:609–18.
DOI: https://doi.org/10.1530/EJE-12-0627
Mitchell JE, Hellkamp AS, Mark DB, et al. Thyroid function in heart failure and impact on mortality. JACC Heart Fail 2013;1:48–55.
DOI: https://doi.org/10.1016/j.jchf.2012.10.004
Cittadini A, Salzano A, Iacoviello M, et al. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry. Eur J Prev Cardiol 2021;28:1691-700.
DOI: https://doi.org/10.1093/eurjpc/zwab020
Iervasi G, Pingitore A, Landi P, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003;107:708–13.
DOI: https://doi.org/10.1161/01.CIR.0000048124.64204.3F
Kannan L, Shaw PA, Morley MP, et al. Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ Heart Fail 2018;11:e005266.
DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.118.005266
Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007;116:1725–35.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.678326
Tomisti L, Materazzi G, Bartalena L, et al. Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. J Clin Endocrinol Metab 2012;97:3515–21.
DOI: https://doi.org/10.1210/jc.2012-1797
Al-Ghamdi AS, Aljohani N. Graves’ thyrotoxicosis-induced reversible cardiomyopathy: a case report. Clin Med Insights Case Rep 2013;6:47–50.
DOI: https://doi.org/10.4137/CCRep.S10534
Choudhury RP, MacDermot J. Heart failure in thyrotoxicosis, an approach to management. Br J Clin Pharmacol 1998;46:421–4.
DOI: https://doi.org/10.1046/j.1365-2125.1998.00804.x
Osman F, Franklyn JA, Holder RL, et al. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol 2007;49:71–81.
DOI: https://doi.org/10.1016/j.jacc.2006.08.042
Salzano A, Marra A., Ferrara F. Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction. Int J Cardiol 2016;225:1-3.
DOI: https://doi.org/10.1016/j.ijcard.2016.09.085
Bastenie PA, Vanhaelst L, Neve P. Coronary-artery disease in hypothyroidism. Lancet 1967;2:1221–2.
DOI: https://doi.org/10.1016/S0140-6736(67)90562-4
Tanis BC, Westendorp GJ, Smelt HM. Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol (Oxf) 1996;44:643–9.
DOI: https://doi.org/10.1046/j.1365-2265.1996.739560.x
Wei JY, Genecin A, Greene HL, Achuff SC. Coronary spasm with ventricular fibrillation during thyrotoxicosis: response to attaining euthyroid state. Am J Cardiol 1979;43:335–9.
DOI: https://doi.org/10.1016/S0002-9149(79)80023-5
Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992;327:94–8.
DOI: https://doi.org/10.1056/NEJM199207093270206
Siu C-W, Zhang X-H, Yung C, et al. Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J Clin Endocrinol Metab 2007;92:1736–42.
DOI: https://doi.org/10.1210/jc.2006-1877
Sugiura T, Yamanaka S, Takeuchi H, et al. Autoimmunity and pulmonary hypertension in patients with Graves’ disease. Heart Vessels 2015;30:642–6.
DOI: https://doi.org/10.1007/s00380-014-0518-3
Vallabhajosula S, Radhi S, Cevik C, et al. Hyperthyroidism and pulmonary hypertension: an important association. Am J Med Sci 2011;342:507–12.
DOI: https://doi.org/10.1097/MAJ.0b013e31821790f4
Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am 2014;43:517–28.
DOI: https://doi.org/10.1016/j.ecl.2014.02.005
Bielecka-Dabrowa A, Mikhailidis DP, Rysz J, Banach M. The mechanisms of atrial fibrillation in hyperthyroidism. Thyroid Res 2009;2:4.
DOI: https://doi.org/10.1186/1756-6614-2-4
Forfar JC, Feek CM, Miller HC, Toft AD. Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy. Int J Cardiol 1981;1:43–8.
DOI: https://doi.org/10.1016/0167-5273(81)90047-4
Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249–52.
DOI: https://doi.org/10.1056/NEJM199411103311901
Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a correctable cause of ‘idiopathic’ atrial fibrillation. Am J Cardiol 1979;44:9–12.
DOI: https://doi.org/10.1016/0002-9149(79)90243-1
Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler 2014;26:296–309.
DOI: https://doi.org/10.1016/j.arteri.2014.07.003
Tănase DM, Ionescu SD, Ouatu A, et al. Risk assessment in the development of atrial fibrillation at patients with associate thyroid dysfunctions. Rev Med Chir Soc Med Nat Iasi 2013;117:623-9.
Chaker L, Heeringa J, Dehghan A, et al. Normal thyroid function and the risk of atrial fibrillation: the Rotterdam study. J Clin Endocrinol Metab 2015;100:3718–24.
DOI: https://doi.org/10.1210/jc.2015-2480
Staffurth JS, Gibberd MC, Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 1977;2:688–90.
DOI: https://doi.org/10.1136/bmj.2.6088.688
Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med 2004;164:1675–8.
DOI: https://doi.org/10.1001/archinte.164.15.1675
Elbers LPB, Fliers E, Cannegieter SC. The influence of thyroid function on the coagulation system and its clinical consequences. J Thromb Haemost 2018;16:634–45.
DOI: https://doi.org/10.1111/jth.13970
Kellett HA, Sawers JS, Boulton FE, et al. Problems of anticoagulation with warfarin in hyperthyroidism. Q J Med 1986;58:43–51.
Goldstein SA, Green J, Huber K, et al. Characteristics and outcomes of atrial fibrillation in patients with thyroid disease (from the ARISTOTLE Trial). Am J Cardiol 2019;124:1406-12.
DOI: https://doi.org/10.1016/j.amjcard.2019.07.046
Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228–38.
DOI: https://doi.org/10.1001/jama.291.2.228
Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002;137:904–14.
DOI: https://doi.org/10.7326/0003-4819-137-11-200212030-00011
Biondi B, Bartalena L, Cooper DS, et al. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J 2015;4:149–63.
DOI: https://doi.org/10.1159/000438750
Nanchen D, Gussekloo J, Westendorp RGJ, et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab 2012;97:852–61.
DOI: https://doi.org/10.1210/jc.2011-1978
Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ 2012;345:e7895.
DOI: https://doi.org/10.1136/bmj.e7895
Selmer C, Olesen JB, Hansen ML, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab 2014;99:2372–82.
DOI: https://doi.org/10.1210/jc.2013-4184
Spencer C, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987;33:1391–6.
DOI: https://doi.org/10.1093/clinchem/33.8.1391
De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999;84:151–64.
DOI: https://doi.org/10.1210/jcem.84.1.5364
Hamilton MA, Stevenson LW, Fonarow GC, et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 1998;81:443-7.
DOI: https://doi.org/10.1016/S0002-9149(97)00950-8
Bartalena L, Bogazzi F, Chiovato L, et al. 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J 2018;7:55-66.
DOI: https://doi.org/10.1159/000486957
Abbara A, Clarke SA, Brewster R, et al. pharmacodynamic response to anti-thyroid drugs in Graves' hyperthyroidism. Front Endocrinol (Lausanne) 2020;11:286.
DOI: https://doi.org/10.3389/fendo.2020.00286
How to Cite
Mattesi, Giulia, Sara Di Michele, Donato Mele, Ilaria Rigato, Riccardo Bariani, Andrea Fiorencis, Marco Previtero, et al. 2022. “Thyroid Dysfunction on the Heart: Clinical Effects, Prognostic Impact and Management Strategies”. Monaldi Archives for Chest Disease 92 (4). https://doi.org/10.4081/monaldi.2022.2145.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Francesco Orio, Teresa Cascella, Francesco Giallauria, Stefano Palomba, Anna De Lorenzo, Rosa Lucci, Elena Ambrosino, Gaetano Lombardi, Annamaria Colao, Carlo Vigorito, The polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women , Monaldi Archives for Chest Disease: Vol. 66 No. 1 (2006): Cardiac series
- Evgenia I. Kalamara, Evangelos T. Ballas, Georgia Pitsiou, Guergana Petrova, Pulmonary rehabilitation for cystic fibrosis: A narrative review of current literature , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Vera Auchynka, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Varvara Solodovnikova, Dzmitry Katovich, Svetlana Setkina, Askar Yedilbayev, Aliaksandr Skrahin, Alena Skrahina, Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Lilit Gevorgyan, Ruzanna Grigoryan, Kostyantyn Dumchev, Kristina Akopyan, Anush Khachatryan, Eduard Kabasakalyan, Trdat Grigoryan, Marina Safaryan, Vardan Avagyan, Sayohat Hasanova, Alberto Matteelli, Factors associated with unfavourable treatment outcomes in people with HIV-associated tuberculosis in Armenia, 2015 to 2019 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Valeriu Plesca, Ana Ciobanu, Yuliia Sereda, Andrei Dadu, Do catastrophic costs impact treatment outcomes in people with rifampicin-resistant tuberculosis in the Republic of Moldova? , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Andrea Bonelli, Roberto Lorusso, Sara Paris, Giovanni Troise, Abu Hilal Mohammed, Francesca Bursi, Pompilio Faggiano, Active cancer and cardiac surgery: Possible scenarios in patient decision-making , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Francesco Giallauria, Rosa Lucci, Francesco Pilerci, Anna De Lorenzo, Athanasio Manakos, Marianna Psaroudaki, Mariantonietta D’Agostino, Alessandra Vitelli, Luigi Maresca, Domenico Del Forno, Carlo Vigorito, Efficacy of Telecardiology in improving the results of Cardiac Rehabilitation after acute myocardial infarction , Monaldi Archives for Chest Disease: Vol. 66 No. 1 (2006): Cardiac series
- M. Malerba, G. Romanelli, Early cardiovascular involvement in Chronic Obstructive Pulmonary Disease , Monaldi Archives for Chest Disease: Vol. 71 No. 2 (2009): Pulmonary series
- Nicola Barbarito, A strange case of severe but fleeting hypoxemia in patient with COVID-19 infection: maybe virus-induced pulmonary Raynaud’s phenomenon? , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Oscar Serafini, Francesco Greco, Gianfranco Misuraca, Mario Chiatto, Antonino Buffon, Echocardiography in the diagnostic and prognostic evaluation of thromboembolic pulmonary hypertension , Monaldi Archives for Chest Disease: Vol. 64 No. 2 (2005): Cardiac series
<< < 28 29 30 31 32 33 34 35 36 37 > >>
You may also start an advanced similarity search for this article.
